Amicus Therapeutics, Inc. (FOLD)

NASDAQ: FOLD · Real-Time Price · USD

Compare

14.29

+0.02 (0.14%)

At close: Jan 30, 2026, 4:00 PM EST

14.24

-0.05 (-0.35%)

After-hours: Jan 30, 2026, 7:28 PM EST

Amicus Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	190.55	213.75	246.99	148.81	245.2	163.24
Short-Term Investments	73.29	36.19	39.21	144.78	237.3	320.03
Cash & Short-Term Investments	263.84	249.95	286.2	293.6	482.5	483.27
Cash Growth	5.64%	-12.67%	-2.52%	-39.15%	-0.16%	6.74%
Receivables	113.84	101.1	87.63	66.2	52.67	46.92
Inventory	177.93	118.78	59.7	23.82	26.82	19.56
Prepaid Expenses	38.46	34.91	49.53	40.21	34.85	29.72
Total Current Assets	594.07	504.74	483.06	423.82	596.83	579.47
Property, Plant & Equipment	49.31	51.66	57.98	60.31	63.08	67.16
Goodwill	197.8	197.8	197.8	197.8	197.8	197.8
Other Intangible Assets	14.74	17.2	20.49	23	-	-
Long-Term Deferred Charges	-	-	-	-	23	23
Other Long-Term Assets	12.9	13.64	18.55	19.24	24.43	19.1
Total Assets	868.81	785.03	777.88	724.17	905.14	886.52
Accounts Payable	19.1	12.95	15.12	15.41	21.51	17.06
Accrued Expenses	171.17	100.49	121.44	80.23	87.8	92.75
Current Portion of Leases	8.66	8.46	8.32	8.55	7.41	6.87
Current Income Taxes Payable	-	18.11	12.43	5.94	6.15	-
Other Current Liabilities	-	8.71	10.37	28.88	23.1	12.99
Total Current Liabilities	198.93	148.7	167.69	139.02	145.98	129.68
Long-Term Debt	391.99	390.11	387.86	391.99	389.36	389.25
Long-Term Leases	42.17	45.08	48.88	51.58	43.36	45.6
Long-Term Unearned Revenue	-	-	-	-	5.91	7.41
Long-Term Deferred Tax Liabilities	-	-	-	-	4.93	4.9
Other Long-Term Liabilities	5.3	7.1	13.28	18.53	8.24	23.3
Total Liabilities	638.39	590.99	617.71	601.12	597.77	600.14
Common Stock	3.02	2.94	2.92	2.82	2.81	2.65
Additional Paid-In Capital	2,974	2,926	2,836	2,665	2,595	2,309
Retained Earnings	-2,769	-2,740	-2,684	-2,532	-2,296	-2,045
Comprehensive Income & Other	22.83	5.17	5.31	-12.02	5.06	20.61
Shareholders' Equity	230.42	194.05	160.17	123.05	307.37	286.38
Total Liabilities & Equity	868.81	785.03	777.88	724.17	905.14	886.52
Total Debt	442.82	443.64	445.06	452.12	440.13	441.73
Net Cash (Debt)	-178.98	-193.7	-158.86	-158.53	42.37	41.54
Net Cash Growth	-	-	-	-	1.99%	-82.87%
Net Cash Per Share	-0.58	-0.64	-0.54	-0.55	0.16	0.16
Filing Date Shares Outstanding	308.53	300.12	295.38	282.71	280.03	264.32
Total Common Shares Outstanding	308.5	299.04	293.59	281.11	278.91	262.06
Working Capital	395.14	356.03	315.37	284.8	450.86	449.79
Book Value Per Share	0.75	0.65	0.55	0.44	1.10	1.09
Tangible Book Value	17.88	-20.95	-58.11	-97.75	109.57	88.58
Tangible Book Value Per Share	0.06	-0.07	-0.20	-0.35	0.39	0.34
Land	-	-	-	-	3.19	3.19
Machinery	-	25.13	24.15	23.63	25.62	23.94
Construction In Progress	-	0.26	3.81	4.16	8.23	5.87
Leasehold Improvements	-	32.36	28.03	24.16	24.17	24.15

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q